Literature DB >> 28279547

Performance of a Random Glucose Case-Finding Strategy to Detect Undiagnosed Diabetes.

Michael E Bowen1, Lei Xuan2, Ildiko Lingvay3, Ethan A Halm4.   

Abstract

INTRODUCTION: Random glucose <200 mg/dL is associated with undiagnosed diabetes but not included in screening guidelines. This study describes a case-finding approach using non-diagnostic random glucose values to identify individuals in need of diabetes testing and compares its performance to current screening guidelines.
METHODS: In 2015, cross-sectional data from non-fasting adults without diagnosed diabetes or prediabetes (N=7,161) in the 2007-2012 National Health and Nutrition Examination Surveys were analyzed. Random glucose and survey data were used to assemble the random glucose, American Diabetes Association (ADA), and U.S. Preventive Services Task Force (USPSTF) screening strategies and predict diabetes using hemoglobin A1c criteria.
RESULTS: Using random glucose ≥100 mg/dL to select individuals for diabetes testing was 81.6% (95% CI=74.9%, 88.4%) sensitive, 78% (95% CI=76.6%, 79.5%) specific and had an area under the receiver operating curve (AROC) of 0.80 (95% CI=0.78, 0.83) to detect undiagnosed diabetes. Overall performance of ADA (AROC=0.59, 95% CI=0.58, 0.60), 2008 USPSTF (AROC=0.62, 95% CI=0.59, 0.65), and 2015 USPSTF (AROC=0.64, 95% CI=0.61, 0.67) guidelines was similar. The random glucose strategy correctly identified one case of undiagnosed diabetes for every 14 people screened, which was more efficient than ADA (number needed to screen, 35), 2008 USPSTF (44), and 2015 USPSTF (32) guidelines.
CONCLUSIONS: Using random glucose ≥100 mg/dL to identify individuals in need of diabetes screening is highly sensitive and specific, performing better than current screening guidelines. Case-finding strategies informed by random glucose data may improve diabetes detection. Further evaluation of this strategy's effectiveness in real-world clinical practice is needed.
Copyright © 2017 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28279547      PMCID: PMC5438773          DOI: 10.1016/j.amepre.2017.01.023

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  25 in total

1.  Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement.

Authors:  Albert L Siu
Journal:  Ann Intern Med       Date:  2015-10-27       Impact factor: 25.391

2.  Screening for hyperglycemia: the gateway to diabetes prevention and management for all Americans.

Authors:  K M Venkat Narayan; Mary Beth Weber
Journal:  Ann Intern Med       Date:  2015-06-02       Impact factor: 25.391

3.  Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

Authors:  S E Kahn; R L Prigeon; D K McCulloch; E J Boyko; R N Bergman; M W Schwartz; J L Neifing; W K Ward; J C Beard; J P Palmer
Journal:  Diabetes       Date:  1993-11       Impact factor: 9.461

Review 4.  Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.

Authors:  Steven E Kahn; Mark E Cooper; Stefano Del Prato
Journal:  Lancet       Date:  2013-12-03       Impact factor: 79.321

5.  The Diabetes Prevention Program (DPP): description of lifestyle intervention.

Authors: 
Journal:  Diabetes Care       Date:  2002-12       Impact factor: 19.112

6.  Utility of the U.S. Preventive Services Task Force criteria for diabetes screening.

Authors:  Sarah Stark Casagrande; Catherine C Cowie; Judith E Fradkin
Journal:  Am J Prev Med       Date:  2013-08       Impact factor: 5.043

7.  Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2.

Authors:  David C Ziemer; Paul Kolm; Jovonne K Foster; William S Weintraub; Viola Vaccarino; Mary K Rhee; Rincy M Varughese; Circe W Tsui; David D Koch; Jennifer G Twombly; K M Venkat Narayan; Lawrence S Phillips
Journal:  J Gen Intern Med       Date:  2008-03-12       Impact factor: 5.128

8.  Self-reported prevalence of diabetes screening in the U.S., 2005-2010.

Authors:  Sarah Stark Casagrande; Catherine C Cowie; Saul M Genuth
Journal:  Am J Prev Med       Date:  2014-09-16       Impact factor: 5.043

9.  Age, BMI, and race are less important than random plasma glucose in identifying risk of glucose intolerance: the Screening for Impaired Glucose Tolerance Study (SIGT 5).

Authors:  David C Ziemer; Paul Kolm; William S Weintraub; Viola Vaccarino; Mary K Rhee; Jane M Caudle; Jade M Irving; David D Koch; K M Venkat Narayan; Lawrence S Phillips
Journal:  Diabetes Care       Date:  2008-02-29       Impact factor: 19.112

10.  Analysis of guidelines for screening diabetes mellitus in an ambulatory population.

Authors:  Ann M Sheehy; Grace E Flood; Wen-Jan Tuan; Jinn-ing Liou; Douglas B Coursin; Maureen A Smith
Journal:  Mayo Clin Proc       Date:  2010-01       Impact factor: 7.616

View more
  6 in total

1.  Multilevel Variation in Diabetes Screening Within an Integrated Health System.

Authors:  Udoka Obinwa; Adriana Pérez; Ildiko Lingvay; Luigi Meneghini; Ethan A Halm; Michael E Bowen
Journal:  Diabetes Care       Date:  2020-03-05       Impact factor: 19.112

2.  Doc, I Just Ate: Interpreting Random Blood Glucose Values in Patients with Unknown Glycemic Status.

Authors:  Michael E Bowen; Lei Xuan; Ildiko Lingvay; Ethan A Halm
Journal:  J Gen Intern Med       Date:  2018-02       Impact factor: 5.128

Review 3.  Building Toward a Population-Based Approach to Diabetes Screening and Prevention for US Adults.

Authors:  Michael E Bowen; Julie A Schmittdiel; Jeffrey T Kullgren; Ronald T Ackermann; Matthew J O'Brien
Journal:  Curr Diab Rep       Date:  2018-09-19       Impact factor: 4.810

4.  Random plasma glucose predicts the diagnosis of diabetes.

Authors:  Mary K Rhee; Yuk-Lam Ho; Sridharan Raghavan; Jason L Vassy; Kelly Cho; David Gagnon; Lisa R Staimez; Christopher N Ford; Peter W F Wilson; Lawrence S Phillips
Journal:  PLoS One       Date:  2019-07-19       Impact factor: 3.240

5.  Patient, Provider, and System Factors Associated With Failure to Follow-Up Elevated Glucose Results in Patients Without Diagnosed Diabetes.

Authors:  Michael E Bowen; Zahra Merchant; Kazeen Abdullah; Deepa Bhat; Jason Fish; Ethan A Halm
Journal:  Health Serv Res Manag Epidemiol       Date:  2017-08-29

6.  Characteristics of undiagnosed diabetes in men and women under the age of 50 years in the Indian subcontinent: the National Family Health Survey (NFHS-4)/Demographic Health Survey 2015-2016.

Authors:  Kajal T Claypool; Ming-Kei Chung; Andrew Deonarine; Edward W Gregg; Chirag J Patel
Journal:  BMJ Open Diabetes Res Care       Date:  2020-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.